Chlamydia Infection Treatment Market Focusing on Growth Strategies and Business Prospectus 2027

The chlamydia infection treatment market is expected to cross USD 12,821.5 million by 2027 at a CAGR of 10%. Chlamydia is a Sexually Transmitted Infection (STI) caused by Chlamydia trachomati.

Sponsored Link Spot Available — Get This Spot According to MRFR analysis, the global chlamydia infection treatment marketis expected to register a CAGR of~10% from 2021 to 2027and hold a value of USD 12,821.5 million till 2027.

The rise in sexually transmitted disease and increasing prevalence of chlamydia drives the growth of the chlamydia infection treatment market. Moreover, increasing awareness among the population for STDs and rising government initiatives to spread awareness for STDs is further driving the growth of the market. According to the Centers for Disease Control and Prevention (CDC), the chlamydial infection has the highest prevalence in people aged ≤24 years in the US. Moreover, asymptomatic infection is also very common among people. Therefore, annual screening of all sexually active women aged
Contact Email
[email protected]
Issued By
vijay k
Country
India
Categories
Health
Last Updated
October 12, 2021

Disclaimer: This press release was submitted by a registered PRBASE contributor and has not been verified or endorsed by PRBASE. PRBASE assumes no responsibility or liability for its accuracy, content, legality, or reliability. The contact email for this release can be viewed here. See our Disclaimer.

Delete Press Release · Edit Press Release